KAT13A Recombinant Antibody, Cy5.5 Conjugated
Applications
Reactivity
| Overview | |
| Catalog # | bsm-61780r-Cy5.5-100uL |
| Product Name | KAT13A Recombinant Antibody, Cy5.5 Conjugated |
| Applications |
WB
IF(IHC-P)
|
| Reactivity | Human |
| Specifications | |
| Conjugation | Cy5.5 |
| Host | Rabbit |
| Source | KLH conjugated synthetic peptide derived from human KAT13A |
| Clonality | Recombinant |
| Isotype | IgG |
| Concentration | Lot dependent |
| Purification | Purified by Protein A. |
| Storage Buffer | Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| Storage Condition | Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target | |
| Gene ID | 8648 |
| Swiss Prot | Q15788 |
| Subcellular location | Cytoplasm, Nucleus, Cell membrane |
| Synonyms | bHLHe74; mNRC 1; NCoA 1; RIP160; SRC 1. |
| Background | Nuclear receptor coactivator that directly binds nuclear receptors and stimulates the transcriptional activities in a hormone-dependent fashion. Involved in the coactivation of different nuclear receptors, such as for steroids (PGR, GR and ER), retinoids (RXRs), thyroid hormone (TRs) and prostanoids (PPARs). Also involved in coactivation mediated by STAT3, STAT5A, STAT5B and STAT6 transcription factors. |
| Application Dilution | |
| WB | 1:500-2000 |
| IF(IHC-P) | IFIHC-P1:50-200 |
Frequently asked questions
Which applications is KAT13A Recombinant Antibody, Cy5.5 Conjugated (BSM-61780R-CY5-5) validated for, and at what dilution?
BSM-61780R-CY5-5 is validated for WB(WB) (1:500-2000); IF(IHC-P)(IF(IHC-P)) (1:50-200). These are recommended starting dilutions; optimal dilutions should be determined by the end user.
Which species does KAT13A Recombinant Antibody, Cy5.5 Conjugated (BSM-61780R-CY5-5) react with?
Tested reactivity: Human.
How should BSM-61780R-CY5-5 be stored?
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. Storage buffer: Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
What immunogen was used to raise KAT13A Recombinant Antibody, Cy5.5 Conjugated (BSM-61780R-CY5-5)?
KLH conjugated synthetic peptide derived from human KAT13A
What are the excitation and emission wavelengths of the Cy5.5 conjugate (BSM-61780R-CY5-5)?
Cy5.5 on BSM-61780R-CY5-5: excitation / emission 675nm/694nm.